SPRY vs. EWTX
SPRY (Silverback Therapeutics Inc) and EWTX (Edgewise Therapeutics Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, SPRY returned -24.00%/yr vs 12.98%/yr for EWTX. At a 0.26 correlation, their price movements are largely independent.
Performance
SPRY vs. EWTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPRY achieves a -34.68% return, which is significantly lower than EWTX's 60.10% return.
SPRY
- 1D
- -1.68%
- 1M
- -22.03%
- 6M
- -32.71%
- YTD
- -34.68%
- 1Y
- -57.49%
- 3Y*
- 3.67%
- 5Y*
- -24.00%
- 10Y*
- —
EWTX
- 1D
- -3.73%
- 1M
- 14.07%
- 6M
- 59.24%
- YTD
- 60.10%
- 1Y
- 185.21%
- 3Y*
- 76.55%
- 5Y*
- 12.98%
- 10Y*
- —
SPRY vs. EWTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
SPRY Silverback Therapeutics Inc | -34.68% | 10.43% | 92.52% | -35.76% | 28.08% | -86.68% |
EWTX Edgewise Therapeutics Inc | 60.10% | -7.06% | 144.06% | 22.37% | -41.49% | -43.41% |
Correlation
The correlation between SPRY and EWTX is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Mar 26, 2021 | 0.26 |
Fundamentals
SPRY:
$755.70M
EWTX:
$4.27B
SPRY:
-$2.00
EWTX:
-$1.67
SPRY:
12.33
EWTX:
8.63
SPRY:
$98.99M
EWTX:
$0.00
SPRY:
$59.93M
EWTX:
$0.00
SPRY:
-$194.60M
EWTX:
-$188.16M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPRY vs. EWTX — Risk / Return Rank
SPRY
EWTX
SPRY vs. EWTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Silverback Therapeutics Inc (SPRY) and Edgewise Therapeutics Inc (EWTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPRY | EWTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.28 | ||
| Sortino ratioReturn per unit of downside risk | -4.50 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.39 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | 9.52 | -10.43 |
| Martin ratioReturn relative to average drawdown | -1.24 | 24.82 | -26.06 |
Loading charts...
Drawdowns
SPRY vs. EWTX - Drawdown Comparison
The maximum SPRY drawdown since its inception was -95.20%, which is greater than EWTX's maximum drawdown of -84.69%. Use the drawdown chart below to compare losses from any high point for SPRY and EWTX.
Loading charts...
Drawdown Indicators
| SPRY | EWTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.20% | -84.69% | -10.51% |
Max Drawdown (1Y)Largest decline over 1 year | -63.32% | -19.59% | -43.73% |
Max Drawdown (3Y)Largest decline over 3 years | -63.32% | -68.81% | +5.49% |
Max Drawdown (5Y)Largest decline over 5 years | -91.77% | -75.41% | -16.36% |
Current DrawdownCurrent decline from peak | -87.40% | -17.83% | -69.57% |
Average DrawdownAverage peak-to-trough decline | -78.34% | -52.76% | -25.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.35% | 7.51% | +38.84% |
Volatility
SPRY vs. EWTX - Volatility Comparison
Silverback Therapeutics Inc (SPRY) has a higher volatility of 31.30% compared to Edgewise Therapeutics Inc (EWTX) at 21.68%. This indicates that SPRY's price experiences larger fluctuations and is considered to be riskier than EWTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPRY | EWTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 31.30% | 21.68% | +9.62% |
Volatility (6M)Calculated over the trailing 6-month period | 49.92% | 45.27% | +4.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.33% | 75.84% | -5.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.62% | 81.63% | -1.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.23% | 81.11% | +0.12% |
Dividends
SPRY vs. EWTX - Dividend Comparison
Neither SPRY nor EWTX has paid dividends to shareholders.
Financials
SPRY vs. EWTX - Financials Comparison
This section allows you to compare key financial metrics between Silverback Therapeutics Inc and Edgewise Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SPRY and EWTX have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SPRY has higher volatility (31.30%) compared to EWTX (21.68%). In terms of maximum drawdown, SPRY dropped -95.20% vs EWTX's -84.69%.
EWTX currently has the higher Sharpe Ratio (2.46 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPRY and EWTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer